178 related articles for article (PubMed ID: 37996237)
1. Determinants of implementing deprescribing for older adults in English care homes: a qualitative interview study.
Warmoth K; Rees J; Day J; Cockcroft E; Aylward A; Pollock L; Coxon G; Craig T; Walton B; Stein K
BMJ Open; 2023 Nov; 13(11):e081305. PubMed ID: 37996237
[TBL] [Abstract][Full Text] [Related]
2. Assessing deprescribing tools for implementation in care homes: A qualitative study of the views of care home staff.
Warmoth K; Rees J; Day J; Cockcroft E; Aylward A; Pollock L; Coxon G; Craig T; Walton B; Stein K
Res Social Adm Pharm; 2024 Apr; 20(4):379-388. PubMed ID: 38245383
[TBL] [Abstract][Full Text] [Related]
3. Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist-led deprescribing in care homes.
Birt L; Wright DJ; Blacklock J; Bond CM; Hughes CM; Alldred DP; Holland R; Scott S
Health Soc Care Community; 2022 Nov; 30(6):e6521-e6531. PubMed ID: 36336895
[TBL] [Abstract][Full Text] [Related]
4. Perspectives of health professionals towards deprescribing practice in Asian nursing homes: a qualitative interview study.
Kua CH; Mak VS; Lee SWH
BMJ Open; 2019 Oct; 9(10):e030106. PubMed ID: 31604786
[TBL] [Abstract][Full Text] [Related]
5. Barriers and enablers to deprescribing for older people in care homes: The theory-based perspectives of pharmacist independent prescribers.
Alharthi M; Wright D; Scott S; Birt L
Res Social Adm Pharm; 2023 May; 19(5):746-752. PubMed ID: 36732210
[TBL] [Abstract][Full Text] [Related]
6. Prescriber Perspectives and Experiences with Deprescribing Versus Continuing Bisphosphonates in Older Nursing Home Residents with Dementia.
Niznik J; Colón-Emeric C; Thorpe CT; Kelley CJ; Gilliam M; Lund JL; Hanson LC
J Gen Intern Med; 2023 Nov; 38(15):3372-3380. PubMed ID: 37369891
[TBL] [Abstract][Full Text] [Related]
7. Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework.
Evrard P; Pétein C; Beuscart JB; Spinewine A
Implement Sci; 2022 Jul; 17(1):41. PubMed ID: 35804428
[TBL] [Abstract][Full Text] [Related]
8. Barriers and facilitators of successful deprescribing as described by older patients living with frailty, their informal carers and clinicians: a qualitative interview study.
Peat G; Fylan B; Marques I; Raynor DK; Breen L; Olaniyan J; Alldred DP
BMJ Open; 2022 Mar; 12(3):e054279. PubMed ID: 35351709
[TBL] [Abstract][Full Text] [Related]
9. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
[TBL] [Abstract][Full Text] [Related]
10. Challenges and Enablers of Deprescribing: A General Practitioner Perspective.
Ailabouni NJ; Nishtala PS; Mangin D; Tordoff JM
PLoS One; 2016; 11(4):e0151066. PubMed ID: 27093289
[TBL] [Abstract][Full Text] [Related]
11. Unlocking Deprescribing Potential in Nursing Homes: Insights from a Focus Group Study with Healthcare Professionals.
Visser AGR; de-Bruijn JBGP; Spaetgens B; Winkens B; Janknegt R; Schols JMGA
Drugs Aging; 2024 Mar; 41(3):261-270. PubMed ID: 38285238
[TBL] [Abstract][Full Text] [Related]
12. Deprescribing research in nursing home residents using routinely collected healthcare data: a conceptual framework.
Thorpe C; Niznik J; Li A
BMC Geriatr; 2023 Aug; 23(1):469. PubMed ID: 37542226
[TBL] [Abstract][Full Text] [Related]
13. Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial.
Nadeau ME; Henry JL; Lee TC; Bortolussi-Courval É; Goodine C; McDonald EG
Trials; 2021 Nov; 22(1):763. PubMed ID: 34727956
[TBL] [Abstract][Full Text] [Related]
14. Healthcare professionals' perspectives of deprescribing in older patients at the end of life in hospice care: a qualitative study using the Theoretical Domains Framework.
Alwidyan T; McCorry NK; Parsons C
Int J Pharm Pract; 2023 May; 31(3):305-313. PubMed ID: 36866441
[TBL] [Abstract][Full Text] [Related]
15. General practitioners' insight into deprescribing for the multimorbid older individual: a qualitative study.
Ailabouni NJ; Nishtala PS; Mangin D; Tordoff JM
Int J Clin Pract; 2016 Mar; 70(3):261-76. PubMed ID: 26918508
[TBL] [Abstract][Full Text] [Related]
16. Determinants of implementing of pet robots in nursing homes for dementia care.
Koh WQ; Toomey E; Flynn A; Casey D
BMC Geriatr; 2022 May; 22(1):457. PubMed ID: 35624435
[TBL] [Abstract][Full Text] [Related]
17. Implementation of interprofessional quality circles on deprescribing in Swiss nursing homes: an observational study.
Mena S; Moullin JC; Schneider M; Niquille A
BMC Geriatr; 2023 Oct; 23(1):620. PubMed ID: 37789286
[TBL] [Abstract][Full Text] [Related]
18. "I simply don't know, because I don't know which drugs I get": Perspectives on deprescribing among older adults with limited life expectancy and their relatives.
Graabaek T; Lundby C; Ryg J; Søndergaard J; Pottegård A; Nielsen DS
Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):115-127. PubMed ID: 32770703
[TBL] [Abstract][Full Text] [Related]
19. Exploration of home care nurse's experiences in deprescribing of medications: a qualitative descriptive study.
Sun W; Tahsin F; Barakat-Haddad C; Turner JP; Haughian CR; Abbass-Dick J
BMJ Open; 2019 May; 9(5):e025606. PubMed ID: 31129579
[TBL] [Abstract][Full Text] [Related]
20. Barriers and enablers to deprescribing in long-term care: A qualitative investigation into the opinions of healthcare professionals in Ireland.
Heinrich CH; McHugh S; McCarthy S; Donovan MD
PLoS One; 2022; 17(12):e0274552. PubMed ID: 36520798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
